69 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
prices, lower reimbursement rates and smaller populations for whom payers will reimburse; changes under the 340B Drug Pricing Program; the company’s
424B5
BMY
Bristol-Myers Squibb Co.
16 Feb 24
Prospectus supplement for primary offering
4:34pm
populations for whom payers will reimburse; changes under the 340B Drug Pricing Program; our ability to obtain and maintain regulatory approval
424B2
lll d20zle4pp7gw
13 Feb 24
Prospectus for primary offering
8:00am
8-K
EX-99.1
t21dho49uoltbaqdzr4
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
424B5
5oighm8 fx7dta
1 Nov 23
Prospectus supplement for primary offering
4:16pm
424B3
lj2f1
30 Oct 23
Prospectus supplement
8:05am
8-K
EX-99.1
3b6d8033cn
26 Oct 23
Bristol Myers Squibb Reports Third Quarter Financial Results for 2023
7:44am
8-K
EX-99.1
ot5jj942s ruh76h
27 Jul 23
Bristol Myers Squibb Reports Second Quarter Financial Results for 2023
7:50am
8-K
EX-99.1
z2z7vpzg gu2m903l
27 Apr 23
Bristol Myers Squibb Reports First Quarter Financial Results for 2023
7:45am
8-K
EX-99.1
la3n81e osqdcy1
26 Oct 22
Bristol Myers Squibb Reports Third Quarter Financial Results for 2022
7:48am
8-K
EX-99.1
m3u4465qlk jvtc73ws3
27 Jul 22
Bristol Myers Squibb Reports Second Quarter Financial Results for 2022
7:44am
8-K
EX-99.1
ohd7g66 mgk2sta8k
29 Apr 22
Bristol Myers Squibb Reports First Quarter Financial Results for 2022
7:42am
8-K
EX-99.2
b44hhv
3 Mar 22
Upsizing and Early Settlement of Tender Offers
4:16pm
8-K
EX-99.1
2zs5dblic kknzse5kj
3 Mar 22
Upsizing and Early Settlement of Tender Offers
4:16pm